21 Panel Drug Test Kits & Alcohol Test Kits

The City of Philadelphia is requesting quotes for 21-panel drug test kits and alcohol test kits under a micro or small order purchase, with quotes due July 20, 2026, to be awarded as a whole or by line item to the lowest responsive and responsible bidder.

Sellers must quote all items to be eligible for award. A fully executed Consent and Authorization Agreement must be submitted prior to bid closing — either attached to the vendor profile during registration or included with the first quote submission. No delivery or services commence until official notification from the department.

The 21-panel drug test kits feature secure, leak-proof click-top lids with built-in temperature strips for sample-integrity validation. Analytes screened include amphetamine, methamphetamine, cocaine, opiates, benzodiazepines, THC, fentanyl, buprenorphine, gabapentin, ketamine, xylazine, synthetic cannabinoids, kratom, and psilocybin, with cut-off thresholds ranging from 10 ng/mL (buprenorphine) to 1,000 ng/mL (amphetamine, methamphetamine, gabapentin, ketamine, xylazine). Three adulterant tests verify sample authenticity. Results are delivered within five minutes via color-strip read-out. The procurement includes alcohol test kits, though specific details are not provided.

The total contract value does not exceed $45,000, adjusted annually by the Consumer Price Index for All Urban Consumers (CPI-U) from January 1, 2020 and rounded to the nearest thousand dollars. The contract term is fixed at 365 days from the effective date specified in PHLContracts, with automatic termination thereafter. Quoted prices must be net and exclusive of taxes. Sellers must maintain minimum insurance coverage: Workers' Compensation at statutory limits, General Liability of $500,000 per occurrence, and Automobile Liability of $300,000 per occurrence. All submissions are completed through www.PHLContracts.phila.gov.